Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,269
Total Claims
$1.6M
Drug Cost
724
Beneficiaries
$2,174
Cost/Patient
Risk Score Breakdown 25/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-9%
Opioid rate vs peers
2.3% vs 2.6% avg
+104%
Cost per patient vs peers
$2,174 vs $1,068 avg
+112%
Brand preference vs peers
19.0% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.3%
Opioid Rate
287
Opioid Claims
$12K
Opioid Cost
22.0%
Long-Acting Rate
Brand vs Generic
Brand: 2,319 claims · $1.3M
Generic: 9,862 claims · $317K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 395 | $169K |
| Dulaglutide | 89 | $91K |
| Empagliflozin | 115 | $60K |
| Dapagliflozin Propanediol | 89 | $55K |
| Mirabegron | 105 | $53K |
| Semaglutide | 33 | $49K |
| Rivaroxaban | 79 | $44K |
| Tirzepatide | 34 | $36K |
| Insulin Glargine/Lixisenatide | 15 | $34K |
| Insulin Degludec | 21 | $33K |
| Rsvpref3 Antigen/As01e/Pf | 105 | $31K |
| Cannabidiol (Cbd) | 11 | $27K |
| Brexpiprazole | 36 | $26K |
| Cariprazine Hcl | 22 | $25K |
| Lumateperone Tosylate | 11 | $25K |
Prescribing Profile
Patient Profile
72
Avg Age
61%
Female
1.17
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About